Could a common drug stop Alzheimer's before it starts?
NCT ID NCT05063851
Summary
This study is testing whether the drug memantine can help prevent Alzheimer's disease in people who are at high risk but don't yet have symptoms. It involves 32 adults aged 50-65 who have a family history of Alzheimer's and carry a specific genetic risk factor. The main goal is to see if this prevention study is practical to run and to gather information for a larger future trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Virginia
Charlottesville, Virginia, 22908, United States
Conditions
Explore the condition pages connected to this study.